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Objective: An accepted fact is that abdominal aortic aneurysms (AAAs) larger than 5.5 cm should undergo elective repair.
However, subsets of these patients have serious comorbid conditions, which greatly increase operative risk. This study
evaluated the outcomes of periods of protracted nonoperative observational management with selective delayed surgery
in patients at high risk with large infrarenal and pararenal AAAs.
Methods: Among 226 patients with AAAs more than 5.5 cm, we selected 72 with AAAs from 5.6 to 12.0 cm (mean, 7.0
cm) for periods of nonoperative management because of their prohibitive surgical risks. Comorbid factors included a low
ejection fraction of 15% to 34% (mean, 22%) in 18 patients, 1 second forced expiratory volume less than 50% (mean, 38%)
in 25, prior laparotomy in 10, and morbid obesity in 22. Follow-up examination was complete in the 72 patients for the
6 to 76 months (mean, 23 months) that they underwent nonoperative treatment. Fifty-three patients ultimately
underwent operation because of AAA enlargement or onset of symptoms after 6 to 72 months (mean, 19 months) of
nonoperative treatment.
Results: Of the 72 selected patients, 54 (75%) are living and 18 (25%) are dead. Seven patients who underwent only
nonoperative treatment presently survive after 28 to 76 months (mean, 48 months). Of the 18 deaths, AAA rupture
occurred in only three patients (4%) who were observed for 12, 31, and 72 months before rupture. Nine other deaths
(13%) occurred after 6 to 72 months from comorbidities unrelated to the AAA. Six of the 53 patients who underwent
delayed operation died within 30 days of operation (11% mortality rate). The mortality rate for the 154 good-risk patients
with an AAA who underwent prompt open or endovascular repair was 2.2%.
Conclusion: These data indicate that some patients with large AAAs and serious comorbidities are acceptably managed for
long periods (6 to 76 months) with nonoperative means. Substantial delays of 12 to 76 months resulted in an AAA
rupture rate of only 4%, and 13% of these patients (nine of 72) died of comorbidities unrelated to AAA rupture or surgery.
Mortality rate in this group of patients, when operated, was 11% (six of 53). These findings support the selective use of
nonoperative management in some patients with large AAAs and serious comorbidities. (J Vasc Surg 2002;36:41-6.)
Current guidelines justify repair of abdominal aortic
aneurysms (AAAs) with a computerized tomographic (CT)
scan or ultrasonographic maximal diameter of 4.5 cm or
more in patients considered to be at standard surgical
risk.1-4 However, the British Small Aneurysm study showed
that mortality rates in patients at standard risk with 4.5-cm
to 5.5-cm AAAs were equivalent whether the initial treat-
ment was surgical or observational.5 That AAAs of more
than 5.5 cm should be repaired with open or endovascular
means is therefore generally accepted. In addition, several
recent reports have described acceptably low operative
mortality rates for open and endovascular AAA repair in
patients with serious comorbidities.6-8 However, little data
exist on the fate of patients with AAAs of more than 5.5 cm
in diameter who are managed nonoperatively for extended
periods because they were considered to be at a prohibitive
risk for either open or endovascular repair because of unfa-
vorable anatomy or serious comorbidities. Moreover, most
of the information that does exist suggests a dire outcome
for such patients.9,10
Because of our early interest in performance of endo-
vascular graft repair of AAAs in patients believed to be at
unacceptably high risk for a major open operation, we had
the opportunity to manage a large number of these pa-
tients, some of whom were also anatomically unsuited for
endovascular repair. Accordingly, we chose to treat 72 of
these patients nonoperatively for extended periods of 6
months or more even when their AAAs exceeded 5.5 cm in
diameter. Although many of these patients eventually un-
derwent AAA repair, this report describes the course and
outcome in the group of patients originally managed non-
operatively.
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MATERIALS AND METHODS
Between January 1, 1994, and July 31, 2000, a total of
226 patients were seen by our vascular surgery group with
unruptured infrarenal or pararenal AAA more than 5.5 cm
in maximal CT scan diameter. All patients underwent a full
medical evaluation. This included a history, physical exam-
ination, 12–lead electrocardiogram, and stress thallium or
stress echocardiogram. Patients more than 70 years of age
and those with cardiac indications underwent thallium
persantine stress tests, and those with particular indications
underwent pulmonary function or other organ-specific
testing.
On the basis of this evaluation, 154 patients were
deemed to be at acceptable risk and underwent prompt
repair of AAA, either with an endovascular (89 patients),
open retroperitoneal (21 patients), or transperitoneal (44
patients) approach. The remaining 72 patients were
deemed to be at unsuitable or unacceptable risk for endo-
vascular repair for anatomic reasons (Table I) or at a pro-
hibitive risk for standard open repair because of major
comorbidities or unacceptable abdominal anatomy (Table
II). To further evaluate operative risk, we used the Ameri-
can Society of Anesthesiology classification scale. The clas-
sifications for these 72 patients were found to be a 5 in nine
patients (12%), a 4 in 61 patients (84%), and an initial score
of 3 in three patients (4%) whose classification ultimately
progressed to a 4 by the end of the study. Only in these
three patients did the status of the comorbidities worsen
during the period of observation.
The 72 patients in this group had AAAs that ranged
from 5.6 to 7.5 cm (mean, 6.2 cm; mode, 6.0 cm) when
first seen (Table III). The total of 17 female patients and 55
male patients had ages that ranged from 70 to 91 years
(mean, 76 years) and 52 to 95 years (mean, 77 years),
respectively. Follow-up examination obtained through
both interviews with their physicians and family and review
of hospital records was complete in all 72 patients for the 6
to 76 months (mean, 23 months) that they were treated
nonoperatively. The AAA size and length of follow-up
period in the 72 patients managed nonoperatively are
shown in Table IV. These patients were seen at 3-month to
6-month intervals, always accompanied with a repeat CT
scan. The size of the initial AAA diameter determined the
length of the interval. Aneurysms that measured 5.6 to 5.9
cm were seen again in 6 months. Any AAA of 6.0 cm or
more on initial presentation was seen at 3-month intervals.
In most cases, an aortogram was also obtained to evaluate
aneurysm anatomy for possible endovascular repair. The
patients and family members were educated repeatedly on
both the recognition and medical emergency of developing
signs and symptoms of an impending AAA rupture. They
were instructed to immediately go to the emergency room
or call 911 for any manifestations of these signs and symp-
toms. Confirmation of the cause of death (n  18) was
obtained through interviews with family, physicians caring
for the patient, review of detailed hospital records, and
death certificates. Family members and physicians were
specifically interrogated whether or not the patient had
syncope or abdominal or back pain before death.
In 53 of these 72 patients, further enlargement (1.0 cm
within 12 months) or the development of pain or AAA
tenderness prompted reevaluation of therapeutic options,
resulting in operative repairs performed after they had been
treated nonoperatively for 6 to 72 months (mean, 19
months; Table V). The 19 remaining patients have been
managed solely with nonoperative means for 6 to 76
months (mean, 29 months; Table VI).
RESULTS
The 30-day operative mortality rate for the 154 good-
risk patients with AAAs more than 5.5 cm was 2.2%. There
were no statistically significant differences in operative mor-
tality rates between those patients who underwent open
and endovascular repair or between those who underwent
retroperitoneal and transperitoneal repair.
Of the 72 patients managed nonoperatively for more
than 6 months, 53 ultimately underwent AAA repair, 26
(49%) because of a 1 cm or more growth within 1 year, 19
Table I. Prohibitive anatomic factors for endovascular
repair in 72 patients managed by nonoperative
treatment*
Factors No. of patients
Pararenal or short neck (1.0 cm) 47
Angulated (90 degrees) or flared neck 32
Small iliac arteries (6.0 mm) 2
Tortuous calcified iliac arteries 8
Failed endovascular attempt 8
*Some patients had more than one factor.
Table II. Risk factors for standard open repair in 72
patients managed by nonoperative treatment*
Factors No. of patients
Low EF (15%-34%; mean, 22%) 18
Intractable CHF 4
Low FEV1 (50%
†, mean 38%) 25
Prior laparotomy 10
Morbid obesity 22
Renal insufficiency (creatinine level  3.5 mg/dL) 7
Large incisional hernia 5
Failed attempt at open AAA repair 3
*Some patients had more than one factor.
†Percent of predicted normal.
EF, Ejection fraction; CHF, congestive heart failure; FEV1, 1-second forced
expiratory volume.
Table III. Distribution of AAA size in 72 patients when
first seen
Size (cm) No. of patients
5.6-5.9 14
6.0-6.9 47
7.0-7.5 11
Mode  6.0 cm.
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(36%) because of abdominal or back pain or both, and eight
(15%) because of aneurysm tenderness. The AAA size dis-
tribution at the time of repair is shown in Table VII, and the
periods of nonoperative observation before operation are
shown in Table V. Operative repair was by one of three
methods: open retroperitoneal (20 patients), open trans-
peritoneal (13 patients), or endovascular (20 patients). The
30-day operative mortality rate in these 53 patients was 11%
(n  6). Periprocedural death occurred in 1 of the 20
patients who had open retroperitoneal repair (5%), 3 of the
13 who had transperitoneal repair (23%), and 2 of the 20
who had endovascular repair (10%). The remaining 47
patients who underwent operation are alive 11 to 71
months after AAA repair (mean, 37 months).
In the group of 19 patients managed solely nonopera-
tively, the periods of nonoperative observation and the
initial and final AAA maximum diameters are shown in
Table VI. Of these 19 patients, seven (37%) are alive after
28 to 76 months (mean, 48 months), nine (47%) have died
of medical comorbidities after 6 to 72 months (mean, 21
months), and three (16%) have died of AAA rupture after
12, 31, and 72 months (mean, 38 months). These three
patients who died of AAA rupture constitute only 4% of the
entire group of 72 patients treated nonoperatively for more
than 6 months (range, 6 to 76 months). Of the nine
patients who died of medical comorbidities, none had had
syncope or abdominal or back pain before or during their
terminal episode. Furthermore, because all nine patients
were known to have large AAAs, CT scans were obtained
during the terminal hospitalization in seven of these nine
patients to evaluate the status of their aneurysms. The only
two patients who did not undergo a CT scan were those
who died of metastatic lung and colon carcinoma. The
official CT scan reports on the seven patients revealed an
intact AAA with no evidence of rupture. The causes of
death in these nine patients were intractable congestive
heart failure in four, electrocardiogram-documented and
cardiac enzyme–documented myocardial infarction in two,
metastatic lung carcinoma in one, metastatic colon carci-
noma in one, and congestive heart failure with multisystem
organ failure in one.
DISCUSSION
That AAAs of more than 5.5 cm in maximal diameter
should be repaired is generally accepted. Even when pa-
tients have serious cardiac and pulmonary comorbidities,
reasonably low AAA repair operative mortality rates have
been achieved, so that repair can be advocated in some
patients at relatively high risk.6,7 Moreover, retroperitoneal
approaches have permitted successful open AAA repair in
patients with extensive intraperitoneal scarring, incisional
hernias, and abdominal gastrointestinal stomas.11-16 In
addition, the availability in the last decade of endovascular
grafts for AAA repair (EVAR) provides the opportunity to
treat AAAs in patients who would otherwise be at a prohib-
itive risk for a major open operation.8,17 As technology
continues to advance, one can speculate that the decision to
Table IV. AAA size and length of follow-up period in 72 patients for nonoperative management
Minimum Maximum Mean
Size of AAA at presentation (cm) 5.6 7.5 6.2  0.52
Duration of nonoperative management and follow-up period (months) 6 76 23  18
Size of AAA at last observation (cm) 6.0 12.0 7.0  1.2
Table V. Time between first evaluation and AAA repair
in 53 patients
Months No. of patients
6-12 13
13-24 15
25-36 10
37-48 7
49-60 5
61-72 3
Table VI. Time between first evaluation and last
observation and AAA sizes in 19 patients treated solely
nonoperatively
Length of
follow-up
(months)
AAA size at
initial
evaluation (cm)
AAA size at
last evaluation
(cm)
Growth of
AAA
(cm/y)
6 6.0 6.0† 0
11 6.1 6.4† 0.32
12 5.6 6.2‡ 0.60
12 5.8 8.0* 1.58
14 5.7 6.5† 0.80
18 5.6 6.0† 0.27
18 5.7 6.0† 0.20
22 7.2 8.0† 0.43
24 5.6 6.0† 0.20
28 6.0 7.9‡ 0.81
29 5.9 6.7† 0.33
29 5.6 6.5‡ 0.37
31 7.5 12.0* 1.74
35 5.6 6.2† 0.20
36 5.7 7.6‡ 0.63
41 5.6 6.5‡ 0.26
54 5.6 6.3‡ 0.15
72 5.7 6.8* 0.20
76 5.6 6.8‡ 0.18
29 (mean) 5.9 (mean) 7.0 (mean) 0.52 (mean)
*Ruptured AAA.
†Died because of medical comorbidities.
‡Alive.
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use EVAR will be more frequent for the patients at both
high and standard risk.
Despite these advances, there remain a substantial pro-
portion of patients who are at prohibitive risk for open AAA
repair and who are not good candidates for an endovascular
graft because of arterial anatomic considerations. Some of
these patients have AAAs substantially larger than 5.5 cm in
maximal diameter. In these circumstances, management
decisions are quite difficult.
There is general agreement that rupture rates of un-
treated AAAs of more than 5.5 cm are high. Several studies
reported annual rupture rates of 10% to 14% in AAAs 5.0 to
5.9 cm in maximal diameter.18,19 In addition, a recent
study by Conway et al9 determined the outcome of 106
patients turned down for AAA repair because of age (80
years), patient refusal, and medical comorbidities. On the
basis of AAA sizes at presentation, aneurysms were stratified
into 5.5 to 5.9 cm (23 patients), 6.0 to 7.0 cm (62
patients), and more than 7.0 cm (21 patients). By the end
of 10 years, 76 of the 106 patients had died, 37 (49%)
because of AAA rupture and the remaining 39 (51%) be-
cause of medical comorbidities.9 In an earlier report, Jones,
Cahill, and Gardham10 reported a high (35%) AAA rupture
rate in patients considered unfit for surgery.
In contrast, our observations suggest that nonoperative
management of some large AAAs is appropriate and reason-
ably safe when prohibitive risk factors for open and endo-
vascular repairs are also present. Such conservative manage-
ment was used for periods ranging from 6 to 76 months in
our 72 patients at high risk with an AAA rupture mortality
rate of only 4%. However, in our approach to these cases,
selective delayed surgical or endovascular AAA repair was
used and was an important aspect of our care. It was
ultimately used on 53 of our 72 patients when further AAA
growth, pain, or tenderness became apparent, with rapid
aneurysm growth as the most common indication for an-
eurysm repair. The larger the AAA, the greater the risk from
comorbidities or difficult anatomy we were willing to ac-
cept in undertaking an open or endovascular repair. Be-
cause all 72 subjects possessed the combination of unfavor-
able anatomy and severe medical comorbidities, these
patients were extremely poor candidates for any form of
repair. Despite this, we believed it prudent to continue to
consider a difficult EVAR when treatment was deemed
unavoidable. Thus, ultimately 20 of these patients under-
Fig 1. Kaplan-Meier life table patient survival rates for our 72 patients managed nonoperatively. Top line makes the
assumption that all 47 patients who survived operation would not have ruptured their aneurysms and would have
survived as they did. Lower line is on basis of assumption that all 53 patients who underwent operation died on the date
of operation. Because some patients underwent operation, extrapolation of a precise natural history curve is not
possible. Accordingly, all that can be said is that the natural history curve would lie somewhere between these two lines.
Table VII. Last observed AAA size in 53 patients who
ultimately underwent repair*
Size (cm) No. of patients
6.0-6.5 18 (34%)
6.6-7.0 23 (43%)
7.1-8.0 9 (17%)
8.0-9.0 3 (6%)
*20 retroperitoneal, 13 transperitoneal, 20 endovascular.
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went EVAR and 33 underwent open repair. The high
periprocedural mortality rate of 11% for these AAA repairs
confirms the high risk of AAA repair in these patients.
Moreover, it certainly justifies our taking the lower risk of
rupture (4%) during the protracted period of nonoperative
management of these patients.
Determination of the precise natural history of the 53
patients who underwent AAA repair is not possible. How-
ever, if one were to assume that all 47 patients who survived
surgery would never have had ruptured aneurysms, 54 of
the 72 patients would still be alive as they are (Fig 1; upper
line). Conversely, if one assumes that all 53 patients died on
the date of their operation from AAA rupture, then only
seven of the total patients would be alive after 6 years (Fig
1; lower line). The expected course of these patients likely
lies between these two lines, perhaps approximating the
survival curve in our 19 patients who were treated solely
nonoperatively (Fig 2).
Our experience with these patients to date has also
decreased our sense of urgency in management of large
AAAs in general. It also supports the recent tendency to
treat smaller AAAs (5.5 cm) nonoperatively with frequent
CT scan or ultrasonographic observations.5 Finally, it
makes a strong case against those who are advocating the
open or endovascular repair of AAAs less than 4.5 cm.
Generally, we do not advocate any form of repair for
asymptomatic stable AAAs less than 5.0 cm. We also gen-
erally do not advise EVAR until AAAs exceed 5.4 cm in
diameter, unless the aneurysm is symptomatic, rapidly en-
larging, or present in a small woman. We also believe that it
is inappropriate at our present state of knowledge for
endovascular enthusiasts to perform repairs of these small
AAAs. Moreover, it is likely that most of the studies that
predict high rates of early rupture for small, medium, and
even some larger AAAs have been on the basis of inaccurate
methods for measuring AAA size and growth.
The difference between our results and the results of
other investigators who have reported on nonoperative
treatment of AAAs more than 5.5 cm in patients at high risk
raises one concern. A possible weakness in our study is the
fact that the absence of AAA rupture was not confirmed
with autopsy in any of our nine patients who died of other
causes. However, all these patients had other plausible and
supportable causes of death, and none of them had syncope
or pain in the abdomen, back, or elsewhere. Without these
signs or symptoms, it is extremely unlikely that AAA rup-
ture contributed to their death.20,21 Death from such a
silent AAA rupture is extremely rare unless the patient has
had a recent opening made into the retroperitoneum.
Moreover, the CT scans obtained during the terminal
illness in seven of the nine patients revealed an intact AAA,
unchanged from previous CT scans.
Thus, our findings justify nonoperative management of
some patients at high risk with large AAAs. Repair is not
indicated in every patient with a large AAA, and some
patients with such AAAs are probably best treated conser-
Fig 2. Kaplan-Meier life table analysis of 19 patients with management solely with nonoperative means. Note that this
line falls approximately between the two lines shown in Fig 1. Three deaths in this group were caused by AAA rupture
and nine by comorbidities.
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vatively for extended periods. Of course, such conservative
treatment must be combined with frequent reevaluation to
determine further enlargement or development of signs or
symptoms that may justify the high risks of AAA repair in a
cohort of these patients, as was the case in our study.
However, until more data regarding our approach to the
management of these difficult cases become available, pre-
cise treatment decisions in each individual patient with
multiple high risk factors and a large AAA will remain
challenging.
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